Nelson Dusetti: Our latest results from the Pancreatic Cancer team in Marseille
Nelson Dusetti shared on LinkedIn:
“Colloquium at Martin Luther University Halle-Wittenberg – University Hospital Halle – 23rd October 2024. Institut für Biochemie and Biotechnologie. 5 pm in the small lecture hall of the Institute for Biochemistry (Kurt-Mothes-Str. 3).
I’m happy to present our latest results from the Pancreatic Cancer team in Marseille: ‘Integrating Molecular Insights into Personalized Treatment for Pancreatic Cancer.’
I’m I’ll be there to discuss, exchange ideas, and explore collaborations between our countries and institutions.
Looking forward to seeing you!”
More posts featuring Nelson Dusetti on oncodaily.com
Nelson Dusetti is the scientific Director of the company Predicting Med (CSO) and Chair of TRANSLATE-IT CRCM. He is also research director at INSERM. He is the Head of the Department of Translational Research and Innovative Therapies at CRCM.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023